Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
CANCvsGNOMETF Comparison
Tema Oncology ETF (CANC) belongs to the Tomorrow's Treatments segment. Global X Genomics & Biotechnology ETF - USD (GNOM) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.5% for GNOM. CANC is up 3.55% year-to-date (YTD) with +$43M in YTD flows. GNOM performs worse with -4.83% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of CANC and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
CANC vs GNOM performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CANC GNOM | -1.54%-5.57% | +2.94%-6.28% | +3.55%-4.83% | +44.18%+25.75% | n/a-9.66% | n/a-54.21% |
| Flows | CANC GNOM | +$14M- | +$51M-$4M | +$43M-$2M | +$65M-$19M | --$115M | -+$8M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CANC GNOM | +23.29%+24.33% | +25.12%+30.10% | n/a+28.55% | n/a+33.48% |
| Max drawdown | CANC GNOM | -5.18%-14.34% | -17.26%-22.14% | n/a-46.50% | n/a-72.17% |
| Max drawdown duration | CANC GNOM | 17d50d | 80d113d | n/a1033d | n/a1716d |
CANC | GNOM | |
Last sale 3/13/2026 at 1:30 PM | $35.99 | $43.24 |
| Previous close 03/12/2026 | $36.33 | $43.61 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
CANC | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
CANC | GNOM | |
|---|---|---|
| Last price | $35.99 | $43.24 |
| 1D performance | -0.95% | -0.84% |
| AuM | $162.12 M | $47.44 M |
| E/R | 0.99% | 0.5% |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the CANC and GNOM ETFs performed in 2026?
As of March 13, 2026, CANC is up 3.55% year-to-date (YTD), while GNOM has lost -4.83%. That puts CANC better performer ahead so far this year.
Which ETF is attracting more investor money: CANC or GNOM?
Year-to-date, the CANC ETF saw +$43M in flows, compared to -$2M for GNOM.
Which ETF is more volatile: CANC or GNOM?
Over the past year, CANC had a volatility of 25.12%, while GNOM experienced 30.1%.
Which ETF is bigger: CANC or GNOM?
As of March 13, 2026, CANC holds $162.12 M in assets under management (AUM), while GNOM manages $47.44 M.
What sectors do the CANC and GNOM ETFs invest in?
CANC leans toward sectors like Health Care. Meanwhile, GNOM focuses on Health Care.
What are the top holdings of the CANC ETF and GNOM ETF?
CANC top holdings include REVOLUTION MEDICINES INC, BRIDGEBIO PHARMA and NOVARTIS. GNOM holds in its top three: MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070.
Which ETF is more diversified: CANC or GNOM?
CANC holds 56 securities with 56.2% of its assets in the top 15. GNOM has 48 securities and a top 15 weight of 63.95%.
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
